• No se han encontrado resultados

Identification of highly altered genes in breast cancer patients through the integration of multiple omics data

N/A
N/A
Protected

Academic year: 2020

Share "Identification of highly altered genes in breast cancer patients through the integration of multiple omics data"

Copied!
93
0
0

Texto completo

Loading

Figure

Figure 1.1: Main steps on a microarray based experiment. Image extracted from http://slideplayer.com/slide/8024786/
Figure 1.2: Main steps on an RNA-seq based experiment, extracted from (Jeffrey and J. Wang 2011)
Figure 3.1: Summary of the pipeline followed during the work.
Figure 4.2: PC1 vs. PC2 of the Principal Component Analysis of the transcription data: red dots represent tumor samples, while blue dots represent normal samples.
+7

Referencias

Documento similar

Analysis of breast cancers from The Cancer Genome Atlas (TCGA) showed that HSD17B14 expression is increased significantly in cancer compared with normal breast tissue and that it

a) To systematically review the indicators of PPF in breast cancer. i) To study the associations between the main constructs from positive psychology and breast cancer. ii)

We ended up with a total of 43 candidate variants from which we finally selected 25 as putative susceptibility alleles for hereditary breast cancer after performing

We tested, by RT-PCR, the expression levels of TWIST1 in normal and tumor paired-sample tissues from a series of 151 colorectal cancer patients, in order to investigate its

Pembrolizu- mab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): results from the targeted agent and profiling utiliza- tion

Triple-negative breast cancer (TNBC) is am immunohistochemically-defined breast cancer subtype negative for ER, PR and HER2 expression, with dismal prognosis that

The two major breast cancer susceptibility genes BRCA1 and BRCA2 are involved in 30% of hereditary breast cancer cases, but the discovery of additional breast cancer

• Cancer-associated stroke is another possible underlying etiology in patients with ESUS (2) and data from the NAVIGATE trial reported a cancer diagnosis in up to 7.5% of the